Literature DB >> 9380731

Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

G S Firestein1, F Echeverri, M Yeo, N J Zvaifler, D R Green.   

Abstract

The factors that regulate the perpetuation and invasiveness of rheumatoid synovitis have been the subject of considerable inquiry, and the possibility that nonimmunologic defects can contribute to the disease has not been rigorously addressed. Using a mismatch detection system, we report that synovial tissue from the joints of severe chronic rheumatoid arthritis patients contain mutant p53 transcripts, which were not found in skin samples from the same patients or in joints of patients with osteoarthritis. Mutant p53 transcripts also were identified in synoviocytes cultured from rheumatoid joints. The predicted amino acid substitutions in p53 were identical or similar to those commonly observed in a variety of tumors and might influence growth and survival of rheumatoid synoviocytes. Thus, mutations in p53 and subsequent selection of the mutant cells may occur in the joints of patients as a consequence of inflammation and contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380731      PMCID: PMC23522          DOI: 10.1073/pnas.94.20.10895

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

Authors:  L Banks; G Matlashewski; L Crawford
Journal:  Eur J Biochem       Date:  1986-09-15

2.  Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.

Authors:  G S Firestein; K Nguyen; K R Aupperle; M Yeo; D L Boyle; N J Zvaifler
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

3.  Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.

Authors:  R Lafyatis; E F Remmers; A B Roberts; D E Yocum; M B Sporn; R L Wilder
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.

Authors:  J M Alvaro-Gracia; N J Zvaifler; G S Firestein
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  p53 mutations in colorectal cancer.

Authors:  N R Rodrigues; A Rowan; M E Smith; I B Kerr; W F Bodmer; J V Gannon; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis.

Authors:  E F Remmers; R Lafyatis; G K Kumkumian; J P Case; A B Roberts; M B Sporn; R L Wilder
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy.

Authors:  M Grootveld; E B Henderson; A Farrell; D R Blake; H G Parkes; P Haycock
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

9.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Authors:  J V Gannon; R Greaves; R Iggo; D P Lane
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

10.  Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.

Authors:  R Bucala; C Ritchlin; R Winchester; A Cerami
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  107 in total

1.  Analysis of synovial biopsy samples: opportunities and challenges.

Authors:  P P Tak
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

2.  Screening of the entire coding region of p53 in low grade lymphoproliferative disorders.

Authors:  T J Bromidge; D J Howe
Journal:  Mol Pathol       Date:  2000-08

3.  Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study.

Authors:  Devapregasan Moodley; Girish M Mody; Anil A Chuturgoon
Journal:  Clin Rheumatol       Date:  2010-06-10       Impact factor: 2.980

4.  The p53 status in juvenile chronic arthritis and rheumatoid arthritis.

Authors:  H Taubert; B Thamm; A Meye; F Bartel; A K Rost; D Heidenreich; V John; J Brandt; M Bache; P Würl; H Schmidt; D Riemann
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 5.  Gene targeting: roadmap to future therapies.

Authors:  Lars C Huber; Thomas Pap; Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

6.  Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.

Authors:  Satoshi Yamasaki; Naoko Yagishita; Takeshi Sasaki; Minako Nakazawa; Yukihiro Kato; Tadayuki Yamadera; Eunkyung Bae; Sayumi Toriyama; Rie Ikeda; Lei Zhang; Kazuko Fujitani; Eunkyung Yoo; Kaneyuki Tsuchimochi; Tomohiko Ohta; Natsumi Araya; Hidetoshi Fujita; Satoko Aratani; Katsumi Eguchi; Setsuro Komiya; Ikuro Maruyama; Nobuyo Higashi; Mitsuru Sato; Haruki Senoo; Takahiro Ochi; Shigeyuki Yokoyama; Tetsuya Amano; Jaeseob Kim; Steffen Gay; Akiyoshi Fukamizu; Kusuki Nishioka; Keiji Tanaka; Toshihiro Nakajima
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

Review 7.  Infection, inflammation, and gastrointestinal cancer.

Authors:  C R Boland; M G Luciani; C Gasche; A Goel
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

8.  The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth.

Authors:  David K Rhee; Jose Marcelino; MacArthur Baker; Yaoqin Gong; Patrick Smits; Véronique Lefebvre; Gregory D Jay; Matthew Stewart; Hongwei Wang; Matthew L Warman; John D Carpten
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

9.  Analyses of synovial tissues from arthritic and protected congenic rat strains reveal a new core set of genes associated with disease severity.

Authors:  Max Brenner; Teresina Laragione; Pércio S Gulko
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

10.  CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression.

Authors:  Jaejoon Lee; Hyemin Jeong; Eun-Jung Park; Ji Won Hwang; Bo Huang; Eun-Kyung Bae; Joong Kyong Ahn; Hoon-Suk Cha; Eun-Mi Koh
Journal:  Rheumatol Int       Date:  2013-03-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.